HUM-MOLGEN events: Cambridge Healthtech Institute's BEYOND GENOME 2003: RNAI, Bioinformatics, Proteomics, Systems Biology

HUM-MOLGEN -> Events -> Meetings and Conferences

Cambridge Healthtech Institute's BEYOND GENOME 2003: RNAI, Bioinformatics, Proteomics, Systems Biology

January 28, 2003

Cambridge Healthtech Institute, San Diego Concourse, 202 C Street MS57, San Diego, CA 92101
June 16-19, 2003

2003 CONFERENCE TOPICS

Beyond Genome is the must attend conference and expo for researchers and business executives interested in hearing the most innovative ideas and information in drug discovery and development directly from the leaders who are creating the newest technologies and most exciting applications. Beyond Genome will incorporate the most cutting edge information available in the Post-Genomic Era.
Click on the conference title for additional information

A major bottleneck in drug discovery remains the consolidation of data and the reduction of noise from large-scale gene and protein expression studies. Computational methods have been used to explore the inherent complexity in biology and form the basis of a comprehensive framework that is critical to honing in on disease targets and their binding sites. The data-intensive approach to leveraging information from disparate databases will produce a framework for exploring biological pathways and the molecular relationships within those pathways. This infrastructure requires an interoperability of multiple databases, as well as the integration of key reference points such as time parameters, clinical conditions, and patient data. Strategies for accomplishing data reduction and gaining insight into identifying druggable leads will be discussed. click here for more info

RNA interference (RNAi) is a powerful, highly conserved process by which sequence-specific RNA selectively targets and silences gene expression in plants and animals post-transcription. Potentially, this process has major implications for drug development and drug target validation. This meeting will address the latest basic and applied research tools, techniques, and methods to explore RNAi and its potential role in these ways. It will also compare RNAi with other knock-out and knock-down tools for target validation. click here for more info

As protein identification and characterization technologies are improving, the bottleneck is shifting from generating proteomic information to applying it. CHI's Seventh Annual Proteomics conference will highlight the latest developments in protein profiling and functional proteomics, with greatest emphasis placed on deriving maximum value from the generated information in therapeutic and diagnostic development.
click here for more info

Advisors and Chairs
Dr. John Doyle, California Institute of Technology
Dr. Michael Hucka, California Institute of Technology
Dr. Len Pennacchio, Lawrence Berkeley National Laboratory
Advances in genomics and proteomics have increased our understanding of biological systems at the molecular level. Systems Biology modeling can elucidate how individual system components interact, integrate, and function to form a complex organism. Examples of computational modeling, in conjunction with empirical research, are providing a greater understanding of disease states and target prioritization. This combination may increase the probability of successful drug development. This conference will bring together experts from life and computational sciences to discuss the state of the field. Anyone interested in Systems Biology tools, methods, and concepts to develop or improve drug development strategies should attend this conference.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

Computational Systems Biology of Peroxisome Biogenesis
Dr. Benno Schwikowski, Assistant Professor, Institute for Systems Biology

The Biomolecular Interaction Database: Curating Molecular Assembly Information Worldwide
Dr. Christopher W.V. Hogue, Scientist, Samuel Lunenfeld Research Institute; and Assistant Professor, Department of Biochemistry, University of Toronto

Computational Tools for Analyzing High-Throughput Mass Spectrometry of Microbial Proteins
Dr. William Cannon, Senior Research Scientist, Computational Biosciences, Pacific Northwest National Laboratory

Zoltan Szallasi, MD, Assistant professor, Children's Hospital Informatics Program, Harvard Medical School
Dr. Stephen Naylor, Chief Technology Officer, Beyond Genomics, Inc
Dr. Rolf Apweiler, Head of Sequence Database Group, EMBL Outstation, European Bioinformatics Institute

Deadline for Abstracts:

May 9, 2003

Registration:

Available Online-REGISTER BY FEBRUARY 14, 2003 AND SAVE $250! email: chi@healthtech.com call: 617-630-1300/fax: 617-630-1325

E-mail:

eeskedal@healthtech.com

Posted by:

elaine eskedal

Host:

wks152.healthtech.com